Oncology Podcasts
Episode 1

Why treat with Xofigo®▼ (radium-223 dichloride)?
Description
Listen to experts in the field as they discuss the benefits and challenges of treatment with radium-223 dichloride and why they consider it as an option for eligible metastatic castration-resistant prostate cancer (mCRPC) patients in their clinics.
Speakers:
- Dr Omi Parikh - Consultant Clinical Oncologist
- Ellie Cradock - Molecular Radiotherapy Manager
This promotional podcast series has been initiated and funded by Bayer and is for healthcare professionals only.
Download Reflective Learning Guide
Speakers
PP-XOF-GB-0462 | February 2024